| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/22/2008 | US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 05/22/2008 | US20080118515 Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases |
| 05/22/2008 | US20080118514 Using toll-like receptor 4 specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory bowel, atherosclerotic and arthritic disorders |
| 05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118510 Vegf-related protein |
| 05/22/2008 | US20080118499 Using concentration of golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) as diagnostic indicator of beta-site amyloid precursor protein cleaving enzyme (BACE) activity and prognostic tool for detection of cardiovascular, nervous sytem and cell proliferative disorders |
| 05/22/2008 | US20080118497 Using presence of single nucleotide polymorphism in transient receptor potential channel gene(TRPC) as diagnostic/prognostic tool in detecting idiopathic pulmonary arterial hypertension (IPAH) |
| 05/22/2008 | US20080118495 Using avian cells as screening tools in monitoring and/or identifying viricidal agents |
| 05/22/2008 | US20080118493 Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity |
| 05/22/2008 | US20080118492 Treating inflammatory disorders via oral administration of protease |
| 05/22/2008 | US20080118491 Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms |
| 05/22/2008 | US20080118490 Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 05/22/2008 | US20080118489 Charge-Modified Lysozyme Antimicrobial Compositions, Surfactants, and Methods for Infections and Cystic Fibrosis |
| 05/22/2008 | US20080118488 Multiple antioxidant micronutrients in the management of diabetes mellitus |
| 05/22/2008 | US20080118487 Cell growth factor polypeptide for use in enhancing muscle growth and treatment muscular disorders |
| 05/22/2008 | US20080118480 Methods and Compositions for Directing Migration of Neural Progenitor Cells |
| 05/22/2008 | US20080118470 Recombinant viral vector comprising adenoviral backbone and coding colony stimulating factor for selective killing of neoplastic cells |
| 05/22/2008 | US20080118469 Anti-angiogenic methods and compositions |
| 05/22/2008 | US20080118466 Treatment of rheumatoid arthritis with soluble fas-ligand cross-linkers |
| 05/22/2008 | US20080118465 Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption |
| 05/22/2008 | US20080118464 For diagnosis, genetic engineering; post-translation modification |
| 05/22/2008 | US20080118463 Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof |
| 05/22/2008 | US20080118462 Biomarkers for Melanoma |
| 05/22/2008 | US20080118437 Therapy for bone metastasis; antibody, antisense or siRNA inhibits expression of MCP-1; docetaxel chemotherapy agent; measure level of expression of MCP-1 relative to non-cancerous prostate tissue; determine treatment course |
| 05/22/2008 | US20080118434 Genes Commonly Regulated by Different Classes of Antidepressants |
| 05/22/2008 | US20080115559 Method for Operating a Reservoir-Based Sensor Device |
| 05/22/2008 | US20080115361 Protecting chemicals and devices from exposure to environment until usage; covering each individual opening with removable barrier layer; eliminates microvalves; controlled in vivo drug release |
| 05/22/2008 | CA2702370A1 Compositions and methods for immunotherapy |
| 05/22/2008 | CA2678131A1 Colonic delivery using zn/pectin beads with a eudragit coating. |
| 05/22/2008 | CA2670260A1 Thiophene analogues for the treatment or prevention of flavivirus infections |
| 05/22/2008 | CA2669969A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb3, hsdl2 and/or ldb2 |
| 05/22/2008 | CA2669891A1 Expression system of nell peptide |
| 05/22/2008 | CA2669832A1 Improved methods and compositions for wound healing |
| 05/22/2008 | CA2669696A1 Stabilized maml peptides and uses thereof |
| 05/22/2008 | CA2669669A1 Intra-vascular kidney gene therapy with plasmid encoding bmp-7 |
| 05/22/2008 | CA2669641A1 Thrombin mutant |
| 05/22/2008 | CA2669599A1 Systemic administration of colony stimulating factors to treat amyloid associated disorders |
| 05/22/2008 | CA2669524A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | CA2669523A1 Aptamer against midkine and use thereof |
| 05/22/2008 | CA2669496A1 Treatment of ectoparasitic infestation |
| 05/22/2008 | CA2669495A1 Animal feeds and veterinary compositions |
| 05/22/2008 | CA2669162A1 Novel amides acting on the adenosine receptors |
| 05/22/2008 | CA2668764A1 Novel compositions for the treatment of various inflammatory conditions |
| 05/22/2008 | CA2667460A1 Synthetic peptide amides and dimers thereof |
| 05/22/2008 | CA2667414A1 Methods and compositions for modification of the human glucocorticoid receptor locus |
| 05/22/2008 | CA2666182A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | CA2665480A1 Glycerol linked pegylated sugars and glycopeptides |
| 05/22/2008 | CA2664866A1 Methods and collagen products for tissue repair |
| 05/21/2008 | EP1923465A1 Inhibitor protein for the WNT signal pathway |
| 05/21/2008 | EP1923463A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 05/21/2008 | EP1923400A1 Compositions and methods for the treatment of systemic lupus erythematosis |
| 05/21/2008 | EP1923068A1 System and methods for opening obstructed biological conduits |
| 05/21/2008 | EP1923060A1 Combinations of a sphingolipid and an HMG-CoA reductase inhibitor for treating hypercholesterolemia |
| 05/21/2008 | EP1922410A2 Gene disruptions, compositions and methods relating thereto |
| 05/21/2008 | EP1922334A1 Tumor-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine |
| 05/21/2008 | EP1922333A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/21/2008 | EP1922328A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 05/21/2008 | EP1922327A2 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 05/21/2008 | EP1922086A1 Targeted protein kinase c inhibitors and uses thereof |
| 05/21/2008 | EP1922083A2 Truncated memapsin 2 for use for treating alzheimer's disease |
| 05/21/2008 | EP1922082A2 New uses of glucoregulatory proteins |
| 05/21/2008 | EP1922081A2 Interferon lambda therapy for treatment of respiratory diseases |
| 05/21/2008 | EP1922080A2 Methods for treating b-cell malignancies using taci-ig fusion molecule |
| 05/21/2008 | EP1922079A2 Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules |
| 05/21/2008 | EP1922078A2 Polypeptides useful for appetite suppression |
| 05/21/2008 | EP1682578B1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 05/21/2008 | EP1537195A4 Desinfecting composition |
| 05/21/2008 | EP1531791A4 Prevention and reduction of blood loss |
| 05/21/2008 | EP1517705B1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 05/21/2008 | EP1495318A4 Method for detecting ligands and targets in a mixture |
| 05/21/2008 | EP1482981B1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/21/2008 | EP1389217B1 Antimicrobial polypeptide |
| 05/21/2008 | EP1372652B1 Combination of docetaxel and flavopiridol |
| 05/21/2008 | EP1360202B1 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 05/21/2008 | EP1319069B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/21/2008 | EP1313453B1 Particulate vectors for improving oral absorption of active principles |
| 05/21/2008 | EP1287130B1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/21/2008 | EP1242111B1 An animal model for studying hormone signalling and method of modulating the signalling |
| 05/21/2008 | EP1227837B1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/21/2008 | EP1161262B1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS |
| 05/21/2008 | EP1150714B1 Methods for inhibiting brain tumor growth |
| 05/21/2008 | EP1097173B1 The use of peptides of il-2 and derivatives thereof as therapeutic agents |
| 05/21/2008 | EP1078002B1 Peptide antiangiogenic drugs |
| 05/21/2008 | EP1064005B1 Urokinase plasminogen activator receptor as a target for diagnosis of micrometastases |
| 05/21/2008 | EP1054687B1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 05/21/2008 | EP1004315B1 Preventives and/or remedies containing anti-il-6 receptor neutralizing antibodies for reducing the excretion of urinary protein in systemic lupus erythematosus |
| 05/21/2008 | EP1003545B1 Heparin-binding growth factor (hbgf) polypeptides |
| 05/21/2008 | CN101184770A Carrier for targeting nerve cells |
| 05/21/2008 | CN101184769A Diagnostic and therapeutic agents |
| 05/21/2008 | CN101184755A Peptidomimetic compounds and preparation of biologically active derivatives |
| 05/21/2008 | CN101184511A Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 05/21/2008 | CN101184509A Agent for improvement of insulin resistance |
| 05/21/2008 | CN101184502A Polypeptides |
| 05/21/2008 | CN101184499A Intranasal administration of active agents to the central nervous system |
| 05/21/2008 | CN101184498A 细胞核进入性组合物 Into the composition of the nucleus |
| 05/21/2008 | CN101184475A Transdermal absorption accelerator |
| 05/21/2008 | CN101184474A A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 05/21/2008 | CN101182430A Health-care multipurpose washing liquor and method for making same |
| 05/21/2008 | CN101182360A Fusion protein having antibiotic function and uses thereof |